NASDAQ:OPCH - Nasdaq - US68404L2016 - Common Stock - Currency: USD
OPTION CARE HEALTH INC
NASDAQ:OPCH (1/24/2025, 8:00:02 PM)
After market: 21.4652 -8.86 (-29.23%)30.33
+0.33 (+1.1%)
The current stock price of OPCH is 30.33 USD. In the past month the price increased by 32.33%. In the past year, price decreased by -2.44%.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush and Blueprint Medicines also experienced significant gains, impacting investment portfolios positively.
BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.68 | 81.68B | ||
CVS | CVS HEALTH CORP | 8.59 | 68.65B | ||
LH | LABCORP HOLDINGS INC | 17.06 | 20.58B | ||
DGX | QUEST DIAGNOSTICS INC | 17.57 | 17.33B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.57 | 14.45B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 171.68 | 14.05B | ||
DVA | DAVITA INC | 19.18 | 13.96B | ||
CHE | CHEMED CORP | 24.05 | 8.25B | ||
HIMS | HIMS & HERS HEALTH INC | 70.16 | 6.74B | ||
CRVL | CORVEL CORP | 24.23 | 5.86B | ||
GH | GUARDANT HEALTH INC | N/A | 5.83B | ||
RDNT | RADNET INC | 114.43 | 4.74B |
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 5,809 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
OPTION CARE HEALTH INC
3000 Lakeside Dr, Suite 300N
Bannockburn ILLINOIS 60015 US
CEO: John C. Rademacher
Employees: 5809
Company Website: https://optioncarehealth.com/
Investor Relations: https://investors.optioncarehealth.com/
Phone: 13129402443
The current stock price of OPCH is 30.33 USD.
The exchange symbol of OPTION CARE HEALTH INC is OPCH and it is listed on the Nasdaq exchange.
OPCH stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for OPCH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of OPCH.
OPCH does not pay a dividend.
OPCH will report earnings on 2025-02-20, after the market close.
The PE ratio for OPCH is 25.49. This is based on the reported non-GAAP earnings per share of 1.19 and the current share price of 30.33 USD.
The outstanding short interest for OPCH is 2.24% of its float.
ChartMill assigns a technical rating of 6 / 10 to OPCH. When comparing the yearly performance of all stocks, OPCH turns out to be only a medium performer in the overall market: it outperformed 41.87% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to OPCH. While OPCH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months OPCH reported a non-GAAP Earnings per Share(EPS) of 1.19. The EPS increased by -13.14% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.37% | ||
ROA | 6.09% | ||
ROE | 14.64% | ||
Debt/Equity | 0.77 |
ChartMill assigns a Buy % Consensus number of 79% to OPCH. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of -16.12% and a revenue growth 15.5% for OPCH